| 0 (0%) | 06-28 18:07 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 82.45 | 1-year : | 88.79 |
| Resists | First : | 70.59 | Second : | 76.01 |
| Pivot price | 65.33  |
|||
| Supports | First : | 61.81 | Second : | 51.42 |
| MAs | MA(5) : | 64.51 |
MA(20) : | 66.87 |
| MA(100) : | 58.78 |
MA(250) : | 45.86 |
|
| MACD | MACD : | -1.2 |
Signal : | -0.7 |
| %K %D | K(14,3) : | 13 |
D(3) : | 19.9 |
| RSI | RSI(14): 42.6 |
|||
| 52-week | High : | 76.01 | Low : | 28.22 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ EAT ] has closed above bottom band by 33.1%. Bollinger Bands are 24.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 65.14 - 65.41 | 65.41 - 65.66 |
| Low: | 63.12 - 63.42 | 63.42 - 63.7 |
| Close: | 63.65 - 64.1 | 64.1 - 64.53 |
Thu, 28 Mar 2024
Insurers to Cover Novo’s Wegovy for Some Medicare Heart Patients (CVS, AET) - Bloomberg
Wed, 28 Nov 2018
CVS Health Completes Acquisition of Aetna, Marking Start of Transforming Consumer Health Experience - MultiVu
Wed, 28 Nov 2018
CVS finalizes its $70 billion Aetna acquisition - MarketWatch
Mon, 05 Nov 2018
CVS Reports Earnings Below 'Reversion to the Mean' - Investopedia
Tue, 05 Dec 2017
Eight out of 10 Americans are within 10 miles of a CVS - Quartz
Mon, 04 Dec 2017
Why Did CVS Buy Aetna for $69 Billion? - Fortune
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 44 (M) |
| Shares Float | 41 (M) |
| Held by Insiders | 1.4 (%) |
| Held by Institutions | 113.4 (%) |
| Shares Short | 7,070 (K) |
| Shares Short P.Month | 7,880 (K) |
| EPS | 3.36 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -1.05 |
| Profit Margin | 3.5 % |
| Operating Margin | 7.1 % |
| Return on Assets (ttm) | 6.1 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 3.4 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 96.2 |
| EBITDA (p.s.) | 9.3 |
| Qtrly Earnings Growth | -3.6 % |
| Operating Cash Flow | 336 (M) |
| Levered Free Cash Flow | 147 (M) |
| PE Ratio | 19.02 |
| PEG Ratio | 0.7 |
| Price to Book value | -61.06 |
| Price to Sales | 0.66 |
| Price to Cash Flow | 8.49 |
| Dividend | 0.37 |
| Forward Dividend | 0 |
| Dividend Yield | 0.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|